|
|
Volumn 12, Issue 9, 2010, Pages 661-663
|
|
Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: Concerns about the science and the message
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN 2 RECEPTOR;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CANDESARTAN;
LOSARTAN;
PLACEBO;
RAMIPRIL;
TELMISARTAN;
VALSARTAN;
ACUTE HEART INFARCTION;
ANGIOGENESIS;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RISK;
CARCINOGENESIS;
CARDIOVASCULAR DISEASE;
CELL PROLIFERATION;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
EDITORIAL;
HEART FAILURE;
HUMAN;
HYPERTENSION;
LUNG CANCER;
META ANALYSIS;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK REDUCTION;
STROKE;
SYSTEMATIC REVIEW;
TUMOR GROWTH;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
HUMANS;
META-ANALYSIS AS TOPIC;
NEOPLASMS;
RISK FACTORS;
|
|
EID: 77956234831
PISSN: 15246175
EISSN: 17517176
Source Type: Journal
DOI: 10.1111/j.1751-7176.2010.00369.x Document Type: Editorial |
|
Times cited : (4)
|
|
References (8)
|
